SCHEMBL27137997

SCHEMBL27137997

CC(C)(C)OC(=O)n1ccc(=O)n(Cc2cc3c(Cl)nc(Cl)nn3c2)c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ BUB1 O43683 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ MMP3 P08254 1/20 0.31
▸ MMP7 P09237 1/20 0.31
▸ MMP10 P09238 1/20 0.31
▸ MMP8 P22894 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ PIK3CD O00329 1/20 0.30
▸ ABL1 P00519 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ HCK P08631 1/20 0.30
▸ SRC P12931 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ PIK3CA P42336 1/20 0.30
▸ PIK3CB P42338 1/20 0.30
▸ MTOR P42345 1/20 0.30
▸ PIK3CG P48736 1/20 0.30
▸ EPHB4 P54760 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27126075 0.85 HSP90AA1 (0.32) HSP90AA1HSP90AB1BUB1ACHEPIK3CD
SCHEMBL27128758 0.70 KIT (0.33) ACHEPARP1PARP2BRD4P2RX3
SCHEMBL30811811 0.65 NR1H2 (0.40) HSP90AA1HSP90AB1BUB1PIK3CDABL1
SCHEMBL1760804 0.65 NR1H2 (0.40) HSP90AA1HSP90AB1BUB1PIK3CDABL1
SCHEMBL27129708 0.64 RECQL (0.34) —
SCHEMBL18992998 0.64 HSP90AA1 (0.41) HSP90AA1HSP90AB1BUB1PIK3CDABL1
SCHEMBL27124750 0.63 PDE1B (0.32) BRD4
SCHEMBL31630952 0.63 BUB1 (0.46) HSP90AA1HSP90AB1BUB1HTR6
SCHEMBL24400696 0.63 HSP90AA1 (0.43) HSP90AA1HSP90AB1BUB1PIK3CA
SCHEMBL20096773 0.63 HSP90AA1 (0.44) HSP90AA1HSP90AB1BUB1PIK3CDABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 — — US disclosed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150362-A1 Substituted Pyrrolotriazines USP7, UBA7, USP5 HSP90AA1 1690/4885HSP90AB1 1702/4885BUB1 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback